Potential damage in pulmonary arterial hypertension: An experimental study of pressure‐induced damage of pulmonary artery
Source abstract
Abstract
Abstract Pulmonary arterial hypertension (PAH) is associated with elevated pulmonary arterial pressure. PAH prognosis remains poor with a 15% mortality rate within 1 year, even with modern clinical management. Previous clinical studies proposed wall shear stress (WSS) to be an important hemodynamic factor affecting cell mechanotransduction, growth and remodeling, and disease progress in PAH. However, WSS in vivo is typically at most 2.5 Pa and a doubt has been cast whether WSS alone can drive disease progress. Furthermore, our current understanding of PAH pathology largely comes from small animals' studies in which caliber enlargement, a hallmark of PAH in humans, is rarely reported. Therefore, a large‐animal experiment on pulmonary arteries (PAs) is needed to validate whether increased pressure can induce enlargement of PAs caliber. In this study, we use an inflation testing device to characterize the mechanical behavior, both nonlinear elastic behavior and irreversible damage of porcine arteries. The parameters of elastic behavior are estimated from the inflation test at a low‐pressure range before and after over‐pressurization. Then, histological images are qualitatively examined for medial and adventitial layers. This study sheds light on the relevance of pressure‐induced damage mechanism in human PAH.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Pulmonary Hypertension Research and Treatments · Elasticity and Material Modeling · Cardiovascular Function and Risk Factors
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Mechanical Engineering Michigan State University East Lansing Michigan USA
Department of Mechanical Engineering Texas A&M University College Station Texas USA
Funding
National Institutes of Health
References (52)
Show source-provided references
1. 10.1016/S1369-7021(11)70059-110.1016/S1369-7021(11)70059-1 ↗
2. 10.1016/j.cma.2006.06.01810.1016/j.cma.2006.06.018 ↗
3. 10.1016/j.actbio.2006.06.00510.1016/j.actbio.2006.06.005 ↗
4. 10.1007/s10439-013-0928-x10.1007/s10439-013-0928-x ↗
5. 10.1164/ajrccm.159.2.980507510.1164/ajrccm.159.2.9805075 ↗
6. 10.1186/1532-429X-14-8410.1186/1532-429X-14-84 ↗
7. 10.1002/nme.182510.1002/nme.1825 ↗
8. 10.1016/j.actbio.2017.11.05210.1016/j.actbio.2017.11.052 ↗
9. 10.1038/labinvest.370021510.1038/labinvest.3700215 ↗
10. 10.1001/archsurg.1984.0139016004100910.1001/archsurg.1984.01390160041009 ↗
11. 10.1259/bjr.71.850.1021106010.1259/bjr.71.850.10211060 ↗
12. 10.1080/1025584070177174310.1080/10255840701771743 ↗
13. 10.1007/s12289-008-0210-110.1007/s12289-008-0210-1 ↗
14. 10.1093/cvr/cvr19510.1093/cvr/cvr195 ↗
15. 10.1098/rsif.2005.007310.1098/rsif.2005.0073 ↗
16. 10.1016/j.jmbbm.2008.10.00710.1016/j.jmbbm.2008.10.007 ↗
17. 10.1152/ajpheart.00224.200210.1152/ajpheart.00224.2002 ↗
18. 10.1016/0021-9290(94)00091-H10.1016/0021-9290(94)00091-H ↗
19. 10.1016/S0093-6413(97)00007-410.1016/S0093-6413(97)00007-4 ↗
20. 10.1023/A:101083531656410.1023/A:1010835316564 ↗
21. 10.1152/ajpheart.00934.200410.1152/ajpheart.00934.2004 ↗
22. Humphrey J. · 2016
23. Humphrey J. D. · 2013
24. 10.1152/ajpheart.00205.201810.1152/ajpheart.00205.2018 ↗
25. 10.1001/2012.jama.1050310.1001/2012.jama.10503 ↗
26. 10.1016/j.jbiomech.2011.04.02210.1016/j.jbiomech.2011.04.022 ↗
27. Mechanics and function of the pulmonary vasculature: Implications for pulmonary vascular disease and right ventricular function
28. 10.1152/ajpheart.00127.200810.1152/ajpheart.00127.2008 ↗
29. 10.1115/1.320255910.1115/1.3202559 ↗
30. 10.1007/s10439-009-9684-310.1007/s10439-009-9684-3 ↗
31. 10.1159/00022622410.1159/000226224 ↗
32. 10.1016/S0741-5214(99)70317-410.1016/S0741-5214(99)70317-4 ↗
33. 10.1016/j.actbio.2013.07.04410.1016/j.actbio.2013.07.044 ↗
34. 10.1016/j.jacc.2015.03.54010.1016/j.jacc.2015.03.540 ↗
35. 10.1161/HYPERTENSIONAHA.114.0092110.1161/HYPERTENSIONAHA.114.00921 ↗
36. 10.1016/S1010-7940(01)01095-810.1016/S1010-7940(01)01095-8 ↗
37. 10.1139/o57-08010.1139/o57-080 ↗
38. 10.1016/j.jcmg.2008.08.00710.1016/j.jcmg.2008.08.007 ↗
39. 10.1016/j.jsb.2012.06.00710.1016/j.jsb.2012.06.007 ↗
40. 10.1016/j.actbio.2015.01.00310.1016/j.actbio.2015.01.003 ↗
41. 10.1016/j.jmbbm.2017.11.03510.1016/j.jmbbm.2017.11.035 ↗
42. 10.1139/y72-04910.1139/y72-049 ↗
43. 10.1016/0045-7825(87)90107-110.1016/0045-7825(87)90107-1 ↗
44. 10.1152/ajpheart.00378.200910.1152/ajpheart.00378.2009 ↗
45. 10.3389/fmed.2018.0020410.3389/fmed.2018.00204 ↗
46. 10.1016/0003-4975(94)01037-D10.1016/0003-4975(94)01037-D ↗
47. 10.1007/s10439-012-0509-410.1007/s10439-012-0509-4 ↗
48. 10.1186/1532-429X-15-8110.1186/1532-429X-15-81 ↗
49. 10.1098/rsif.2008.025410.1098/rsif.2008.0254 ↗
50. 10.1115/1.283474710.1115/1.2834747 ↗
51. 10.1161/HYPERTENSIONAHA.113.0174410.1161/HYPERTENSIONAHA.113.01744 ↗
52. 10.1007/s10439-015-1461-x10.1007/s10439-015-1461-x ↗